← Back to Search

Digital Mental Health Technologies for Pediatric Mental Health (TeACH Trial)

N/A

Waitlist Available

Research Sponsored by Rush University Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion, an average of once per year.

Awards & highlights

TeACH Trial Summary

This trial will use digital mental health technologies to help improve engagement, assessment, detection, treatment, and delivery of services for pediatric mental health, specifically for underserved teens and their families.

Who is the study for?

This trial is for teens aged 13-17 with symptoms of anxiety disorder, who are getting care at certain Rush University Health System and University of Illinois at Chicago Pediatric Primary Care clinics. They must be able to speak and read English. Teens not meeting these criteria cannot participate.Check my eligibility

What is being tested?

The study tests the TeACH System, a digital mental health technology designed for pediatric mental health care. It involves collaboration with teens and parents (Phase 1), refining the system with healthcare staff (Phase 2), and evaluating it in a randomized trial within primary care clinics (Phase 3).See study design

What are the potential side effects?

Since this trial focuses on digital technologies rather than medications, traditional side effects like those seen with drugs are not applicable. However, there may be non-medical concerns such as privacy issues or stress related to technology use.

TeACH Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ administered to primary care staff through study completion, an average of once per year.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~administered to primary care staff through study completion, an average of once per year.

This trial's timeline: 3 weeks for screening, Varies for treatment, and administered to primary care staff through study completion, an average of once per year. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acceptability of Intervention Measure (AIM)

Anxiety

Anxiety Understanding Maintenance

+11 more

Secondary outcome measures

After-Scenario Questionnaire (ASQ)

After-Scenario Questionnaire (ASQ) Maintenance

COVID-19 Exposure and Family Impact Survey (CEFIS)

+3 more

Other outcome measures

Demographics

TeACH Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: TeACH System ResourcesExperimental Treatment1 Intervention

Patients who screen positive for anxiety will receive stakeholder-informed feedback and resources (i.e., psychoeducation and mental health recommendations).

Group II: Evidence-based ResourcesActive Control1 Intervention

Patients who screen positive for anxiety will receive a link to a webpage providing psychoeducation about anxiety and possible treatment options.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Illinois at ChicagoOTHER

607 Previous Clinical Trials

1,559,055 Total Patients Enrolled

Rush University Medical CenterLead Sponsor

422 Previous Clinical Trials

163,231 Total Patients Enrolled

1 Trials studying Mental Health

35 Patients Enrolled for Mental Health

Media Library

TeACH System Resources Clinical Trial Eligibility Overview. Trial Name: NCT05466929 — N/A

Mental Health Research Study Groups: Evidence-based Resources, TeACH System Resources

Mental Health Clinical Trial 2023: TeACH System Resources Highlights & Side Effects. Trial Name: NCT05466929 — N/A

TeACH System Resources 2023 Treatment Timeline for Medical Study. Trial Name: NCT05466929 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this medical investigation accept participants who are over sixty years of age?

"Per the inclusion guidelines of this clinical trial, teens aged between 13 and 17 are eligible to enroll."

Answered by AI

Who is eligible to partake in this clinical investigation?

"This research trial seeks 276 adolescents aged 13-17 who present symptoms of an anxiety disorder and are receiving care at Rush University Health System Pediatric Primary Care locations. Furthermore, eligible participants should be proficient in English to ensure effective communication."

Answered by AI

Are new participants being enrolled for this clinical trial at the present?

"Clinicaltrials.gov states that recruitment for this study, initially posted on September 1st 2023 and last updated on August 15th 2022, is not currently open. However, there are 52 other trials actively recruiting candidates at the moment."

Answered by AI

What is the ultimate objective of this investigation?

"The primary goal of this trial is to evaluate the efficacy of TeACH System for alleviating anxiety. Secondary metrics include Maintenance (using the 3-item ASQ with a 7 point scale), Program Sustainability Assessment Tool (PSAT) which consists of 40 items, and After Scenario Questionnaire (ASQ). These outcomes will all be measured one week after interaction with the system."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Engagement With DMH Technologies in Pediatric Primary Care

2024. "Engagement With DMH Technologies in Pediatric Primary Care". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05466929.